GPX4 and metabolic dysfunction-associated steatohepatitis: While hepatic glutathione peroxidase 4 (GPX4), a key protector against lipid peroxidation, is increased in murine NASH models, drug-mediated inhibition or activation of GPX4 exacerbates or ameliorates the severity of murine NASH19.